Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Depressive Disorder × Psilocybin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Depression 3 Anxiety Disorders 3 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma 1 Hospice 1 Hematopoietic and Lymphatic System Neoplasm 1 Endocrine Gland Neoplasms 1 Depressive Disorder 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 1 Psilocybin 1 Interviews as Topic 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07216404 2026-02-10

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon ⚡